ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.
作者信息
Olthof Pim B, van Gulik Thomas M
机构信息
Department of Surgery, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, The Netherlands.
Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
出版信息
Ann Surg Oncol. 2020 Jul;27(7):2319-2320. doi: 10.1245/s10434-020-08333-9. Epub 2020 Mar 9.
Abstract
摘要
相似文献
1
ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.
Ann Surg Oncol. 2020 Jul;27(7):2319-2320. doi: 10.1245/s10434-020-08333-9. Epub 2020 Mar 9.
2
Portal Vein Embolization for Perihilar Cholangiocarcinoma: A Story Worth Repeating.
Ann Surg Oncol. 2020 Jul;27(7):2120-2121. doi: 10.1245/s10434-020-08280-5. Epub 2020 Feb 28.
3
ASO Author Reflections: Laparoscopic Surgery of Perihilar Cholangiocarcinoma Between Oncologic Adequacy and Technical Challenges.
Ann Surg Oncol. 2020 Dec;27(13):5193-5194. doi: 10.1245/s10434-020-08660-x. Epub 2020 May 26.
4
Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery: Ultimate superextended surgery for advanced perihilar cholangiocarcinoma.
J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):597-599. doi: 10.1002/jhbp.1102. Epub 2021 Dec 30.
5
ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.
Ann Surg Oncol. 2020 Jul;27(7):2387-2388. doi: 10.1245/s10434-020-08445-2. Epub 2020 Apr 22.
6
ASO Author Reflections: Chasing a Microscopic Cancer-Free Margin During Resection for Perihilar Cholangiocarcinoma: Can Additional Resection Improve the Long-Term Outcomes?
Ann Surg Oncol. 2023 Jun;30(6):3360-3361. doi: 10.1245/s10434-023-13197-w. Epub 2023 Feb 7.
7
ASO Author Reflections: Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Can this Emerging Minimally Invasive Technique Become an Alternative Approach to Open Surgery for Perihilar Cholangiocarcinoma?
Ann Surg Oncol. 2023 Dec;30(13):8012-8013. doi: 10.1245/s10434-023-14298-2. Epub 2023 Sep 19.
8
Narrowing of the remnant portal vein diameter and decreased portal vein angle are risk factors for portal vein thrombosis after perihilar cholangiocarcinoma surgery.
Langenbecks Arch Surg. 2021 Aug;406(5):1511-1519. doi: 10.1007/s00423-020-02044-1. Epub 2021 Jan 6.
9
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma.
Int J Surg. 2020 Oct;82S:97-102. doi: 10.1016/j.ijsu.2020.06.045. Epub 2020 Jul 7.
10
ASO Author Reflections: Total Laparoscopic Resection of Perihilar Cholangiocarcinoma: What is Ahead?
Ann Surg Oncol. 2023 Aug;30(8):4874-4875. doi: 10.1245/s10434-023-13625-x. Epub 2023 May 16.
本文引用的文献
1
Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2020 Jul;27(7):2311-2318. doi: 10.1245/s10434-020-08258-3. Epub 2020 Feb 26.
2
Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
Surgery. 2019 May;165(5):918-928. doi: 10.1016/j.surg.2019.01.010. Epub 2019 Mar 11.
3
A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers.
HPB (Oxford). 2019 Mar;21(3):345-351. doi: 10.1016/j.hpb.2018.07.014. Epub 2018 Aug 4.
4
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.
J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4.
5
Tc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma.
HPB (Oxford). 2017 Oct;19(10):850-858. doi: 10.1016/j.hpb.2017.05.007. Epub 2017 Jul 4.
Zotero 插件